Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications.

Neurogastroenterology and motility - 1 Aug 2007

Camilleri M

Abstract excerpt

Pharmacogenomics of serotonin are potentially relevant in research and clinical practice. There are few proven examples of the importance of pharmacogenetics of serotonin-modifying agents used in functional gastrointestinal or motility disorders. Drug metabolism is dependent on function of the cy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dyspepsia
Share to Gastrointestinal Agents
Share to Indoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, Serotonin

Share to Serotonin

Share to Serotonin Antagonists

Share to Serotonin Plasma Membrane Transport Proteins

Share to Serotonin Receptor Agonists

Source

Identifiers

PMID: 17620087
DOI: 10.1111/j.1365-2982.2007.00961.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17620087-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications.PMID 17620087Read ↗

Pharmacogenetics and the Treatment of Functional Gastrointestinal DisordersSemantic proximity Read ↗

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndromeSemantic proximity Read ↗

Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.Semantic proximity Read ↗

Psychiatric pharmacogenomic testing in clinical practiceSemantic proximity Read ↗

eComment: Serotonin syndrome: pharmacogenomics and treatment.Semantic proximity Read ↗

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapySemantic proximity Read ↗

Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety DisordersSemantic proximity Read ↗

Pharmacogenetic studies: a tool to improve antidepressant therapy.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Semantic proximity Read ↗

Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and diseaseSemantic proximity Read ↗

The genetics of the serotonin transporter and irritable bowel syndromeSemantic proximity Read ↗

Pharmacogenomics and antidepressant drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.